Safety and tolerability of liver-derived stem cells (HepaStem) infused in patients with acute-on-chronic liver failure or acute decompensation: a European phase I/IIa open-labelled study-MedSci.cn

Safety and tolerability of liver-derived stem cells (HepaStem) infused in patients with acute-on-chronic liver failure or acute decompensation: a European phase I/IIa open-labelled study

Frederik, N; Thierry, G; Pierre-Francois, L; Luc, L; Enev, HL; Victor, V; Virginie, B; Clerget-Chossat, N; Sokal, E

JOURNAL OF HEPATOLOGY, 2019; 70 (1): E83

科室
- - 订阅+
  - 更多科室
工具
服务